Fenugreek

• CAS No.: 481-49-2
• Formula: C37H38N2O6
• Packaging Material: Aluminum Foil Bag/Cardboard barrel
• Storage Method: Normal
• Shelf Life: 24 Months
• Nutrient Composition: Mineral
• Resource: Natural
• The content of active substances: 100%
• Transport Package: 25 Kg/Carton Outside and Double Food Plastic Bags
• Specification: 98%
• Trademark: SOST
• Origin: China
• Production Capacity: 10 Kg/Momth

Product Description

Product Description

Fenugreek,It is a bipartite isovaline alkaloid isolated from the plant of the family Antibiotics. It has anti-tumor, anti-malarial, anti-bacterial and immune regulating effects. Modern research suggests that it also has the function of stimulating reticuloendothelial system, activating hematopoietic tissue and promoting bone marrow tissue proliferation, and has been clinically used to prevent leukopenia in tumor patients due to radiotherapy, chemotherapy and other reasons, and has received certain effects. It can partially reverse the multidrug resistance of leukemia cells, which is significantly better than the classical reversal drug verapamil, and the cytotoxic effect is much less than verapamil at the reversal dose. Foreign studies have also shown that chikungunin has a good reversal effect on a variety of drug-resistant cells. The immune function activity of cells and macrophages is enhanced in vivo. In Japan, it has been clinically used as a leukocyte-raising drug for more than a year without obvious toxic side effects. In China, it has been used clinically for many years for experimental treatment of pneumoconiosis. The results of the above studies suggest that the clinical use of Chikungunin is of great value.


1.Antitumor effects
Fenugreek has potential antitumor effects. Chikungunin alone can exert anti-tumor effects by inhibiting tumor cell proliferation and enhancing the immunity of the body. More promisingly, the combination of chikungunin with chemotherapeutic drugs can improve the efficacy of chemotherapy by reducing cellular resistance. The main mechanism may be that chikungunin interferes with the function of plasma membrane to increase the accumulation of anticancer drugs in cells. In addition, chikungunin has the effect of increasing the sensitivity of tumor cells to radiotherapy.

2.Helping women breastfeed their babies
Fenugreek was noted as a remedy used to induce labor. As fenugreek traveled east, it appeared in Traditional Chinese Medicine documents for issues related to abdominal pain, menstrual cramps, and swelling.

3.A leukoproliferative drug that promotes the proliferation of bone marrow tissue, thereby elevating white blood cells. Used in leukopenia. It can increase peripheral blood leukocytes, and animal experiments have found that it can significantly prevent mitomycin-induced leukopenia, but does not inhibit the anticancer effect of mitomycin. Its mechanism of action is to promote the proliferation of bone marrow tissue, thus producing an elevated leukocyte effect. It is used for granulocyte deficiency caused by tumor chemotherapy and radiotherapy and leukopenia caused by other reasons.
 

1.Used as an analgesic use 
2.It can be used as a leukocyte proliferation promoting drug. Used in leukopenia. It can increase peripheral blood leukocytes, and animal experiments have found that it can significantly prevent mitomycin-induced leukopenia, but does not inhibit the anticancer effect of mitomycin. Mild gastrointestinal reactions such as nausea, vomiting and diarrhea occasionally.
 

Product Name:Fenugreek    
Batch Number:FD20110901       Batch Quantity:125kg
Analysis Date:2021/11/15      Manufacture Date:2021/11/09
Expiry Date:2023/11/08
 

Items	Standards	Results
Specification(HPLC)	Cepharanthine≥98%	99.38%
Physical Description
Description	Light Yellow to White Powder	Complies
Odor	Characteristic	Complies
Taste	Characteristic	Complies
Particle size	95% pass 80 mesh	Complies
Ash	≤2.0%	0.0076%
Loss on Drying	≤5.0%	1.04%
Chemical Tests
Heavy metals	≤10ppm	Complies
Pb	≤2ppm	Complies
As	≤2ppm	Complies
Cd	≤0.5ppm	Complies
Hg	≤0.1ppm	Complies
Residue on Ignition	Eur.Pharm	Complies
Microbial
Total Plate Count	≤5000cfu/g	Complies
Yeast&Mould	≤100cfu/g	Complies
Staphylococcus	Negative	Complies
Conclusion	Conform to specification.

You May Like